GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Balance Sheet History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹9.70 Cr | ₹9.70 Cr | ₹9.70 Cr | ₹9.70 Cr | ₹7.78 Cr |
Equity - Authorised | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr |
Equity - Issued | ₹9.70 Cr | ₹9.70 Cr | ₹9.70 Cr | ₹9.70 Cr | ₹7.78 Cr |
Equity Paid Up | ₹9.70 Cr | ₹9.70 Cr | ₹9.70 Cr | ₹9.70 Cr | ₹7.78 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹338 Cr | ₹259 Cr | ₹164 Cr | ₹120 Cr | ₹68 Cr |
Securities Premium | - | - | - | - | - |
Capital Reserves | ₹72 Cr | ₹72 Cr | ₹71 Cr | ₹71 Cr | ₹0.13 Cr |
Profit & Loss Account Balance | ₹267 Cr | ₹189 Cr | ₹94 Cr | ₹50 Cr | ₹66 Cr |
General Reserves | ₹1.35 Cr | ₹1.35 Cr | ₹1.35 Cr | ₹1.35 Cr | ₹1.35 Cr |
Other Reserves | ₹-2.66 Cr | ₹-2.61 Cr | ₹-2.17 Cr | ₹-2.18 Cr | ₹0.11 Cr |
Reserve excluding Revaluation Reserve | ₹338 Cr | ₹259 Cr | ₹164 Cr | ₹120 Cr | ₹68 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹348 Cr | ₹269 Cr | ₹173 Cr | ₹129 Cr | ₹75 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹191 Cr | ₹48 Cr | ₹35 Cr | ₹20 Cr | ₹11 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹195 Cr | ₹50 Cr | ₹33 Cr | ₹16 Cr | ₹12 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-4.34 Cr | ₹-1.72 Cr | ₹2.61 Cr | ₹3.54 Cr | ₹-1.12 Cr |
Unsecured Loans | - | - | - | ₹0.03 Cr | ₹0.06 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | ₹0.03 Cr | ₹0.06 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-0.97 Cr | ₹0.19 Cr | ₹1.49 Cr | ₹-0.64 Cr | ₹-0.69 Cr |
Deferred Tax Assets | ₹3.91 Cr | ₹3.58 Cr | ₹2.69 Cr | ₹2.71 Cr | ₹3.67 Cr |
Deferred Tax Liability | ₹2.95 Cr | ₹3.77 Cr | ₹4.18 Cr | ₹2.08 Cr | ₹2.98 Cr |
Other Long Term Liabilities | ₹21 Cr | ₹5.33 Cr | ₹7.82 Cr | ₹11 Cr | ₹4.68 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹13 Cr | ₹12 Cr | ₹10 Cr | ₹7.93 Cr | ₹1.86 Cr |
Total Non-Current Liabilities | ₹224 Cr | ₹66 Cr | ₹55 Cr | ₹38 Cr | ₹17 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹130 Cr | ₹141 Cr | ₹111 Cr | ₹117 Cr | ₹78 Cr |
Sundry Creditors | ₹130 Cr | ₹141 Cr | ₹111 Cr | ₹117 Cr | ₹78 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹39 Cr | ₹33 Cr | ₹30 Cr | ₹23 Cr | ₹16 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | - | - | ₹2.83 Cr | ₹3.00 Cr | ₹2.65 Cr |
Interest Accrued But Not Due | ₹0.31 Cr | ₹0.23 Cr | ₹0.28 Cr | ₹0.15 Cr | ₹0.30 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | ₹0.04 Cr |
Other Liabilities | ₹39 Cr | ₹33 Cr | ₹27 Cr | ₹20 Cr | ₹13 Cr |
Short Term Borrowings | ₹112 Cr | ₹6.60 Cr | ₹16 Cr | ₹93 Cr | ₹85 Cr |
Secured ST Loans repayable on Demands | ₹112 Cr | ₹6.60 Cr | ₹16 Cr | ₹93 Cr | ₹85 Cr |
Working Capital Loans- Sec | ₹112 Cr | ₹6.60 Cr | ₹16 Cr | ₹93 Cr | ₹85 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-112 Cr | ₹-6.60 Cr | ₹-16 Cr | ₹-93 Cr | ₹-85 Cr |
Short Term Provisions | ₹7.37 Cr | ₹5.55 Cr | ₹6.15 Cr | ₹92 Cr | ₹39 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹3.12 Cr | ₹0.68 Cr | ₹1.58 Cr | ₹86 Cr | ₹36 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹4.24 Cr | ₹4.87 Cr | ₹4.57 Cr | ₹6.62 Cr | ₹3.37 Cr |
Total Current Liabilities | ₹288 Cr | ₹186 Cr | ₹164 Cr | ₹326 Cr | ₹218 Cr |
Total Liabilities | ₹860 Cr | ₹521 Cr | ₹392 Cr | ₹493 Cr | ₹310 Cr |
ASSETS | |||||
Gross Block | ₹246 Cr | ₹180 Cr | ₹149 Cr | ₹115 Cr | ₹37 Cr |
Less: Accumulated Depreciation | ₹87 Cr | ₹64 Cr | ₹49 Cr | ₹32 Cr | ₹13 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹160 Cr | ₹115 Cr | ₹100 Cr | ₹83 Cr | ₹24 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹170 Cr | ₹41 Cr | ₹13 Cr | ₹31 Cr | ₹9.63 Cr |
Non Current Investments | ₹0.78 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Long Term Investment | ₹0.78 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.78 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr | ₹0.01 Cr |
Long Term Loans & Advances | ₹64 Cr | ₹44 Cr | ₹17 Cr | ₹19 Cr | ₹10 Cr |
Other Non Current Assets | ₹1.80 Cr | ₹0.95 Cr | ₹0.98 Cr | ₹1.84 Cr | ₹2.10 Cr |
Total Non-Current Assets | ₹396 Cr | ₹201 Cr | ₹131 Cr | ₹134 Cr | ₹46 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹183 Cr | ₹116 Cr | ₹94 Cr | ₹122 Cr | ₹94 Cr |
Raw Materials | ₹52 Cr | ₹23 Cr | ₹31 Cr | ₹48 Cr | ₹30 Cr |
Work-in Progress | ₹57 Cr | ₹20 Cr | ₹28 Cr | ₹33 Cr | ₹32 Cr |
Finished Goods | ₹37 Cr | ₹39 Cr | ₹20 Cr | ₹28 Cr | ₹17 Cr |
Packing Materials | ₹26 Cr | ₹21 Cr | ₹11 Cr | ₹7.98 Cr | ₹7.38 Cr |
Stores Ā and Spare | - | - | - | - | - |
Other Inventory | ₹12 Cr | ₹12 Cr | ₹4.13 Cr | ₹5.43 Cr | ₹7.48 Cr |
Sundry Debtors | ₹205 Cr | ₹152 Cr | ₹125 Cr | ₹107 Cr | ₹103 Cr |
Debtors more than Six months | ₹19 Cr | ₹13 Cr | ₹9.83 Cr | ₹6.72 Cr | ₹17 Cr |
Debtors Others | ₹191 Cr | ₹143 Cr | ₹118 Cr | ₹104 Cr | ₹91 Cr |
Cash and Bank | ₹47 Cr | ₹27 Cr | ₹13 Cr | ₹16 Cr | ₹7.60 Cr |
Cash in hand | ₹0.04 Cr | ₹0.01 Cr | ₹0.78 Cr | ₹0.55 Cr | ₹0.32 Cr |
Balances at Bank | ₹44 Cr | ₹24 Cr | ₹9.29 Cr | ₹14 Cr | ₹4.61 Cr |
Other cash and bank balances | ₹3.08 Cr | ₹2.46 Cr | ₹3.12 Cr | ₹1.67 Cr | ₹2.66 Cr |
Other Current Assets | ₹1.79 Cr | ₹0.86 Cr | ₹0.69 Cr | ₹0.84 Cr | ₹1.10 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.95 Cr | ₹0.85 Cr | ₹0.58 Cr | ₹0.68 Cr | ₹0.32 Cr |
Other current_assets | ₹0.84 Cr | ₹0.00 Cr | ₹0.11 Cr | ₹0.16 Cr | ₹0.77 Cr |
Short Term Loans and Advances | ₹27 Cr | ₹26 Cr | ₹28 Cr | ₹112 Cr | ₹58 Cr |
Advances recoverable in cash or in kind | ₹8.17 Cr | ₹8.73 Cr | ₹10 Cr | ₹12 Cr | ₹14 Cr |
Advance income tax and TDS | - | - | - | ₹86 Cr | ₹31 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹19 Cr | ₹17 Cr | ₹18 Cr | ₹14 Cr | ₹13 Cr |
Total Current Assets | ₹464 Cr | ₹321 Cr | ₹261 Cr | ₹359 Cr | ₹264 Cr |
Net Current Assets (Including Current Investments) | ₹176 Cr | ₹134 Cr | ₹97 Cr | ₹34 Cr | ₹46 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹860 Cr | ₹521 Cr | ₹392 Cr | ₹493 Cr | ₹310 Cr |
Contingent Liabilities | ₹6.71 Cr | ₹3.90 Cr | ₹14 Cr | ₹37 Cr | ₹4.83 Cr |
Total Debt | ₹311 Cr | ₹61 Cr | ₹55 Cr | ₹117 Cr | ₹98 Cr |
Book Value | 35.88 | 27.76 | 17.89 | 13.34 | 9.68 |
Adjusted Book Value | 35.88 | 27.76 | 17.89 | 13.34 | 9.68 |
Compare Balance Sheet of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹2,975.4 Cr | 0.4% | -7.8% | 52.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | 0.4% |
-7.8% |
52.5% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses